Implementation of a wake-up and unknown symptom onset stroke protocol

Abstract

Background: Establishing a symptom onset timeline for stroke patients is one of the essential aspects of thrombolytic therapy. Implementing an MRI protocol can potentially increase the rate of thrombolytic therapy and expand treatment to patients who would otherwise be excluded.
Objective: This project aimed to increase the rate of thrombolytic therapy by incorporating an additional layer of evaluation within the established acute stroke code process for patients with wake-up stroke (WUS) or unknown symptom onset stroke.
Methods: Patients 18 years of age and older who presented as WUS eligible for thrombolytic therapy underwent acute MRI. Patients with a diffusion weighted image and fluid attenuated inversion recovery mismatch (DWI-FLAIR Mismatch) on MRI were treated with thrombolytic therapy.
Results: Chi-square test of independence showed patients who underwent the MRI protocol (N = 35) had a higher proportion of alteplase (tissue plasminogen activator,tPA) treatment when compared to a similar sample (N = 44) from 2019 acute stoke logs; χ² (1, N = 79) = 8.16, p = .006. Six patients received thrombolytic. Safety showed no symptomatic intracerebral hemorrhage (sICH) or deaths. Conclusions: Results of the project indicated an increased rate of thrombolytic treatment that was statistically significant.

Keywords

Wake-up stroke / Unknown onset / Thrombolysis / Tissue plasminogen activator / Alteplase / Ischemic stroke treatment

CONFLICTS OF INTEREST DISCLOSURE

The authors declare they have no conflicts of interest.

References

[1] Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019; 139(10): e56-e528. PMid: 30700139. https://doi.org/10.1161/CIR.0000000000000659

[2] Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019; 50(12): e344-e418. https://doi.org/10.1161/STR.0000000000000211

[3] Lees KR, Emberson, J, Blackwell L, et al. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of nine trials. Stroke. 2016; 47(9): 2373-2379. PMid: 27507856. https://doi.org/10.1161/STROKEAHA.116.013644

[4] Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018; 379(7): 611-622. PMid: 29766770. https://doi.org/10.1056/NEJMoa1804355

[5] Manawadu D, Bodla S, Jaros J, et al. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients. Stroke. 2013; 44(8): 2226-2231. PMid: 23723307. https://doi.org/10.1161/STROKEAHA.111.000757

[6] Manawadu D, Bodla S, Jarosz J, et al. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke. 2013; 44: 427-431. PMid: 23287781. https://doi.org/10.1161/STROKEAHA.112.673145

[7] Schwamm LH, Wu O, Song S, et al. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS Trial results. Ann Neuro. 2018; 83(5): 980-993. PMid: 29689135. https://doi.org/10.1002/ana.25235

[8] Thomalla G, Cheng B, Ebinger M, et al. STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol. 2011; 10(11): 978-86. https://doi.org/10.1016/S1474-4422(11)70192-2

[9] Ashcraft S, Wilson SE, Nystrom KV, et al. Care of the patient with acute ischemic stroke (prehospital and acute phase of care): Update to the 2009 Comprehensive Nursing Care Scientific Statement: A scientific statement from the American Heart Association. Stroke. 2021; 52(5): e164-e178. PMid: 33691468. https://doi.org/10.1161/STR.0000000000000356

[10] Quinn TJ, Taylor-Rowan M, Coyte A, et al. Pre-stroke Modified Rankin Scale: evaluation of validity, prognostic accuracy, and association with treatment. Front Neurol. 2017; 8: 275. PMid: 28659859. https://doi.org/10.3389/fneur.2017.00275

[11] Camicia M, Lutz B, Summers D, et al. Nursing’s role in successful stroke care transitions across the continuum: From acute care into the community. Stroke. 2021; 52(12): e794-e805. PMid: 27659852. https://doi.org/10.1161/STROKEAHA.116.012095

[12] Jakubicek S, Krebs S, Posekany A, et al. Modified DWI-FLAIR mismatch guided thrombolysis in unknown onset stroke. J Throm Thrombolysis. 2019; 47(2): 167-173. PMid: 30415393. https://doi.org/10.1007/s11239-018-1766-3

[13] Manawadu D, Bodla S, Jarosz J, et al. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients. Stroke. 2013; 44(8): 2226-2231. PMid: 23723307. https://doi.org/10.1161/STROKEAHA.111.000757

[14] Mainali S, Stutzman S, Sengupta S, et al. Feasibility and efficacy of nurse-driven acute stroke care. J Stroke Cerebrovasc Dis. 2017; 26(5): 987-991. PMid: 28012837. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.007

[15] Ripamonti L, Riva R, Maioli F, et al. Daily variations in the occurrence of different subtypes of stroke. Stroke Res Treat. 2017; 1-12. PMid: 28717529. https://doi.org/10.1155/2017/9091250